ACC Ltd. announces an acquisition

The Scheme provides 328 Ambuja Cements shares for every 100 ACC shares, equivalent to 3.28 Ambuja shares per ACC share. ^[1]

What the valuation evidence supports

The available NCLT notice is a procedural notice for ACC shareholders and does not reproduce the valuation report, the standalone book values of ACC and Ambuja Cements, or the valuation methodology. ^[2] Accordingly, the ratio cannot be quantitatively reconciled here to a book-value exchange ratio—for example, by showing that ACC’s book value per share divided by Ambuja’s book value per share equals 3.28.

The transaction documentation identifies GT Valuation Advisors and BDO Valuation Advisory as the joint independent valuers, with fairness opinions from IDBI Capital and SBI Capital Markets. ^[3] However, the cited material does not disclose:

• ACC’s standalone book value or book value per share;
• Ambuja Cements’ standalone book value or book value per share;
• any book-value-based exchange ratio; or
• the valuation range and weighting assigned to market, income or asset-based methods.

Analytical implication: the 328:100 ratio should not be described as being justified solely by relative standalone book values. It is a negotiated valuation-based share exchange ratio, subject to the independent valuation and fairness-opinion process. Without the report’s underlying book values and methodology, the available evidence establishes the exact swap ratio but not whether it represents a premium, discount or parity relative to standalone book value.

ACC’s liabilities would transfer to Ambuja rather than being extinguished. From the Scheme’s appointed date of 1 January 2026, ACC’s business, assets, profits, liabilities and tax obligations are to be treated as those of Ambuja during the transition, with the Scheme expected to become effective in FY27. ^[4]

This would include ACC’s existing debt obligations and, in substance, its contingent-liability exposures. The Scheme-related disclosures specifically require pending or ongoing adjudication, recovery proceedings, prosecutions and other enforcement actions involving ACC to be identified, together with their possible impact on Ambuja. ^[5] Thus, creditors’ claims and unresolved legal or regulatory exposures move into the amalgamated entity; the merger does not provide a general liability waiver.

Net debt-to-equity: the cited Scheme material does not provide a clear, Scheme-specific projected net debt-to-equity ratio for the combined Ambuja–ACC entity. The figures of 0.12x and 0.02x reported in the notice relate to separate borrowing or financial-assistance disclosures, not demonstrably to the post-amalgamation balance sheet, and should not be presented as the merger’s projected ratio. ^[4]

The supported conclusion is therefore qualitative: the combination consolidates ACC’s debt and contingent liabilities onto Ambuja’s balance sheet, while the precise projected change in the combined entity’s net debt-to-equity ratio requires the post-Scheme balance-sheet figures or the relevant financial annexure.

Beyond the NCLT-convened shareholder vote, the disclosed outstanding conditions are:

• Creditor approval, where required.
• Sanction of the Scheme by the NCLT, after the shareholder and creditor processes.
• Other applicable statutory and regulatory approvals, as required under the Scheme and applicable law. The notice states that the Scheme remains subject to subsequent NCLT sanction and other regulatory approvals.^[6]
• The BSE/NSE observation or no-objection letters are described as an earlier procedural step, not final approval; the merger still requires NCLT, shareholder, creditor and other applicable approvals.^[1]

Long Stop Date: The exact “Long Stop Date” is not reproduced in the cited NCLT meeting notice or the accompanying extracts, so it cannot be stated reliably from the available disclosure. The notice confirms the shareholder meeting date as 29 September 2026, but that is not the Scheme’s Long Stop Date.^[2]